346 related articles for article (PubMed ID: 11923849)
1. Nontraditional publications and their effect on patentable inventions.
Garabedian TE
Nat Biotechnol; 2002 Apr; 20(4):401-2. PubMed ID: 11923849
[No Abstract] [Full Text] [Related]
2. US Supreme Court decision could compromise biotech patents.
Robertson D
Nat Biotechnol; 2001 May; 19(5):394. PubMed ID: 11328981
[No Abstract] [Full Text] [Related]
3. Surprise US election results may boost biotech.
Fox JL
Nat Biotechnol; 2002 Dec; 20(12):1176. PubMed ID: 12454655
[No Abstract] [Full Text] [Related]
4. Biotechnology inventions in the health care environment: what to patent and how to avoid defeat.
Murashige KR
Benders Health Care Law Mon; 1995 Dec; ():3-10. PubMed ID: 10158648
[No Abstract] [Full Text] [Related]
5. Patent border wars: defining the boundary between scientific discoveries and patentable inventions.
Holman CM
Trends Biotechnol; 2007 Dec; 25(12):539-43. PubMed ID: 17983675
[TBL] [Abstract][Full Text] [Related]
6. Australia experiments with 'experimental use' exemption.
McBratney A; Nielsen K; McMillan F
Nat Biotechnol; 2004 Aug; 22(8):1023-5. PubMed ID: 15286651
[TBL] [Abstract][Full Text] [Related]
7. Protecting rights to early-stage technology.
Shuster MJ; Su H; Blaug S
Nat Biotechnol; 2003 Jun; 21(6):701-3. PubMed ID: 12776151
[No Abstract] [Full Text] [Related]
8. Patent protection for Aspergillus-related inventions.
Jong SC; Birmingham JM
Biotechnology; 1992; 23():297-311. PubMed ID: 1504603
[TBL] [Abstract][Full Text] [Related]
9. A modest proposal: toward improved access to biotechnology research tools by implementing a broad experimental use exception.
Hoffman DC
Cornell Law Rev; 2004 May; 89(4):993-1043. PubMed ID: 15174465
[No Abstract] [Full Text] [Related]
10. Research interactions between industry and academia: a corporate perspective.
Citron P
Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
[No Abstract] [Full Text] [Related]
11. The 1992 biotechnology agenda: a message for candidates Bush and Clinton.
Duzan SA
Healthspan; 1992 Sep; 9(8):12-5. PubMed ID: 10122052
[No Abstract] [Full Text] [Related]
12. Reexamining the research exemption.
Flores MA; Campbell C
Nat Biotechnol; 2005 Jun; 23(6):659-61. PubMed ID: 15940230
[No Abstract] [Full Text] [Related]
13. Putting your best mode forward.
Tsao YR; Tabtiang RK
Nat Biotechnol; 2000 Oct; 18(10):1113-4. PubMed ID: 11017054
[No Abstract] [Full Text] [Related]
14. Patents. U.S. Supreme Court delves into what is and isn't patentable.
Marshall E
Science; 2009 Jun; 324(5933):1374. PubMed ID: 19520926
[No Abstract] [Full Text] [Related]
15. Biotechnology patents: strategies for meeting economic and ethical concerns.
Gold ER
Nat Genet; 2002 Apr; 30(4):359. PubMed ID: 11925560
[No Abstract] [Full Text] [Related]
16. License and collaboration agreements: protecting your most valuable asset.
Duxbury P; Mellett D
Nat Biotechnol; 2002 Jan; 20(1):91-2. PubMed ID: 11753369
[No Abstract] [Full Text] [Related]
17. No room for experiment: the Federal Circuit's narrow construction of the experimental use defense.
Ludwig SP; Chumney JC
Nat Biotechnol; 2003 Apr; 21(4):453. PubMed ID: 12665827
[No Abstract] [Full Text] [Related]
18. Patent first, ask questions later: morality and biotechnology in patent law.
Bagley MA
William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
[TBL] [Abstract][Full Text] [Related]
19. Supporting the work of lesser geniuses: an argument for removing obstructions to human embryonic stem cell research.
Hazuka CD
Univ Miami Law Rev; 2002 Oct; 57(1):157-220. PubMed ID: 15156896
[No Abstract] [Full Text] [Related]
20. Equivalents in biotechnology patents.
Auer HE
Nat Biotechnol; 2003 Mar; 21(3):329-31. PubMed ID: 12610574
[No Abstract] [Full Text] [Related]
[Next] [New Search]
